- Surprising Reasons You're in Pain Slideshow
- Take the Pain Quiz
- Joint-Friendly Exercises to Reduce RA Pain Slideshow
- Does Zohydro ER (hydrocodone) cause side effects?
- What are the important side effects of Zohydro ER (hydrocodone)?
- Zohydro ER (hydrocodone)? side effects list for healthcare professionals
- What drugs interact with Zohydro ER (hydrocodone)?
- Does Zohydro ER (hydrocodone) cause addiction or withdrawal symptoms?
Does Zohydro ER (hydrocodone) cause side effects?
Zohydro ER (hydrocodone) is an opioid narcotic pain-reliever similar to oxycodone, morphine, methadone, fentanyl, and other opioids prescribed for long-term treatment of severe pain for which other treatment options are not effective, not tolerated, or would most likely not be strong enough to adequately manage the pain.
Zohydro ER, like other opioids, stimulates receptors on nerves in the brain to increase the threshold to pain (the amount of stimulation it takes to feel pain) and reduce the perception of pain (the perceived importance of the pain). Unlike other hydrocodone products such as Vicodin which contain acetaminophen, Zohydro ER contains only hydrocodone.
Common side effects of Zohydro ER include
- constipation, and
- spasm of the ureter, which can lead to difficulty in urinating.
Serious side effects of Zohydro ER include
- impaired thinking and physical abilities required for driving or operating machinery, and
- depressed breathing. Zohydro ER is habit forming.
Mental and physical dependence can occur when used long-term. Withdrawal symptoms may occur if you suddenly stop taking Zohydro ER.
Drug interactions of Zohydro ER include
- other opioids,
- general anesthetics,
- agonist/antagonist analgesics,
- monoamine oxidase inhibitors (MAOIs), and
What are the important side effects of Zohydro ER (hydrocodone)?
The most frequent adverse reactions include:
Other side effects include:
- Spasm of the ureter, which can lead to difficulty in urinating.
Other patient warnings include:
- Hydrocodone can impair thinking and the physical abilities required for driving or operating machinery.
- Hydrocodone can depress breathing, and should be used with caution in elderly, debilitated patients, and in patients with serious lung disease.
- Hydrocodone is habit forming. Mental and physical dependence can occur when used long-term.
Zohydro ER (hydrocodone) side effects list for healthcare professionals
The following serious adverse reactions are discussed elsewhere in the labeling:
- Addiction, Abuse, and Misuse
- Life-Threatening Respiratory Depression
- Neonatal Opioid Withdrawal Syndrome
- Interactions with Benzodiazepines and Other CNS Depressants
- Adrenal Insufficiency
- Severe Hypotension
- Gastrointestinal Adverse Reactions
Clinical Trial Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
- The safety of Zohydro ER was evaluated in a total of 1,148 subjects in Phase 3 clinical trials.
- Table 3 lists the most frequently occurring adverse reactions occurring at a greater frequency than placebo from the placebo-controlled trial in subjects with moderate-to-severe chronic lower back pain.
Table 3. Treatment-Emergent Adverse Events in ≥2% of Subjects During the Open-Label Titration Period and/or the Double-Blind Treatment Period, by Preferred Term — Number (%) of Treated Subjects (Placebo-Controlled Study in Opioid-Experienced Subjects with Moderate-to-Severe Chronic Lower Back Pain)
|Open-Label Titration Period||Double-Blind Treatment Period|
|Zohydro ER||Zohydro ER||Placebo|
|Preferred Term||(N = 510)||(n = 151)||(n = 151)|
|Constipation||56 (11%)||12 (8%)||0 (0%)|
|Nausea||50 (10%)||11 (7%)||5 (3%)|
|Somnolence||24 (5%)||1 (1%)||0 (0%)|
|Fatigue||21 (4%)||1 (1%)||2 (1%)|
|Headache||19 (4%)||0 (0%)||2 (1%)|
|Dizziness||17 (3%)||3 (2%)||1 (1%)|
|Dry mouth||16 (3%)||0 (0%)||0 (0%)|
|Vomiting||14 (3%)||7 (5%)||1 (1%)|
|Pruritus||13 (3%)||0 (0%)||0 (0%)|
|Abdominal pain||8 (2%)||4 (3%)||0 (0%)|
|Edema peripheral||7 (1%)||4 (3%)||0 (0%)|
|Upper respiratory tract infection||7 (1%)||5 (3%)||1 (1%)|
|Muscle spasms||6 (1%)||4 (3%)||2 (1%)|
|Urinary tract infection||4 (1%)||8 (5%)||3 (2%)|
|Back pain||4 (1%)||6 (4%)||5 (3%)|
|Tremor||1 (0%)||4 (3%)||1 (1%)|
The common (≥1% to <10%) adverse drug reactions reported at least once by subjects treated with Zohydro ER in the Phase 3 clinical trials and not represented in Table 3 were:
- Gastrointestinal Disorders: abdominal discomfort, abdominal pain, gastroesophageal reflux disease
- General Disorders and Administration Site Conditions: non-cardiac chest pain, pain, peripheral edema, pyrexia
- Injury, Poisoning and Procedural Complications: contusion, fall, foot fracture, joint injury, joint sprain, muscle strain, skin laceration
- Investigations: increased blood cholesterol, increased gamma-glutamyltransferase
- Metabolism and Nutrition Disorders: dehydration, hypokalemia
- Musculoskeletal and Connective Tissue Disorders: arthralgia, musculoskeletal pain, myalgia, neck pain, osteoarthritis, pain in extremity
- Nervous System Disorders: lethargy, migraine, paresthesia
- Psychiatric Disorders: anxiety, depression, insomnia
- Respiratory, Thoracic, and Mediastinal Disorders: cough, dyspnea
- Skin and Subcutaneous Tissue Disorders: hyperhidrosis, night sweats, rash
- Vascular Disorders: hot flush
The following adverse reactions have been identified during post approval use of hydrocodone. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
- Cases of serotonin syndrome, a potentially life-threatening condition, have been reported during concomitant use of opioids with serotonergic drugs.
- Cases of adrenal insufficiency have been reported with opioid use, more often following greater than one month of use.
- Anaphylaxis has been reported with ingredients contained in Zohydro ER.
- Cases of androgen deficiency have occurred with chronic use of opioids.
What drugs interact with Zohydro ER (hydrocodone)?
|Clinical Impact:||Concomitant use of alcohol with Zohydro ER can result in an increase of hydrocodone plasma levels and potentially fatal overdose of hydrocodone.|
|Intervention:||Instruct patients not to consume alcoholic beverages or use prescription or nonprescription products containing alcohol while on Zohydro ER therapy|
|Inhibitors of CYP3A4 and CYP2D6|
The concomitant use of Zohydro ER and CYP3A4 inhibitors can increase the plasma concentration of hydrocodone, resulting in increased or prolonged opioid effects. These effects could be more pronounced with concomitant use of Zohydro ER and CYP2D6 and CYP3A4 inhibitors, particularly when an inhibitor is added after a stable dose of Zohydro ER is achieved.
After stopping a CYP3A4 inhibitor, as the effects of the inhibitor decline, the hydrocodone plasma concentration will decrease, resulting in decreased opioid efficacy or a withdrawal syndrome in patients who had developed physical dependence to hydrocodone.
If concomitant use is necessary, consider dosage reduction of Zohydro ER until stable drug effects are achieved. Monitor patients for respiratory depression and sedation at frequent intervals.
If a CYP3A4 inhibitor is discontinued, consider increasing the Zohydro ER dosage until stable drug effects are achieved. Monitor for signs of opioid withdrawal.
|Examples:||Macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g. ketoconazole), protease inhibitors (e.g., ritonavir)|
The concomitant use of Zohydro ER and CYP3A4 inducers can decrease the plasma concentration of hydrocodone, resulting in decreased efficacy or onset of a withdrawal syndrome in patients who have developed physical dependence to hydrocodone.
After stopping a CYP3A4 inducer, as the effects of the inducer decline, the hydrocodone plasma concentration will increase, which could increase or prolong both the therapeutic effects and adverse reactions, and may cause serious respiratory depression.
|Intervention:||If concomitant use is necessary, consider increasing the Zohydro ER dosage until stable drug effects are achieved. Monitor for signs of opioid withdrawal. If a CYP3A4 inducer is discontinued, consider Zohydro ER dosage reduction and monitor for signs of respiratory depression.|
|Examples:||Rifampin, carbamazepine, phenytoin|
|Benzodiazepines and other Central Nervous System (CNS) Depressants|
|Clinical Impact:||Due to additive pharmacologic effect, the concomitant use of benzodiazepines or other CNS depressants including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death.|
|Intervention:||Reserve concomitant prescribing of these drugs for use in patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients closely for signs of respiratory depression and sedation|
|Examples:||Benzodiazepines and other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, other opioids, alcohol.|
|Clinical Impact:||The concomitant use of opioids with other drugs that affect the serotonergic neurotransmitter system has resulted in serotonin syndrome.|
|Intervention:||If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Discontinue Zohydro ER if serotonin syndrome is suspected.|
|Examples:||Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that affect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).|
|Monoamine Oxidase Inhibitors (MAOIs)|
|Clinical Impact:||MAOI interactions with opioids may manifest as serotonin syndrome or opioid toxicity (e.g., respiratory depression, coma).|
|Intervention:||The use of Zohydro ER is not recommended for patients taking MAOIs or within 14 days of stopping such treatment.|
|Examples:||Phenelzine, tranylcypromine, linezolid|
|Mixed Agonist/Antagonist and Partial Agonist Opioid Analgesics|
|Clinical Impact:||May reduce the analgesic effect of Zohydro ER and/or precipitate withdrawal symptoms.|
|Intervention:||Avoid concomitant use.|
|Examples:||butorphanol, nalbuphine, pentazocine, buprenorphine|
|Clinical Impact:||Hydrocodone may enhance the neuromuscular blocking action of skeletal muscle relaxants and produce an increased degree of respiratory depression.|
|Intervention:||Monitor patients for signs of respiratory depression that may be greater than otherwise expected and decrease the dosage of Zohydro ER and/or the muscle relaxant as necessary.|
|Clinical Impact:||Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone.|
|Intervention:||Monitor patients for signs of diminished diuresis and/or effects on blood pressure and increase the dosage of the diuretic as needed.|
|Clinical Impact:||The concomitant use of anticholinergic drugs may increase risk of urinary retention and/or severe constipation, which may lead to paralytic ileus.|
|Intervention:||Monitor patients for signs of urinary retention or reduced gastric motility when Zohydro ER is used concomitantly with anticholinergic drugs.|
Does Zohydro ER (hydrocodone) cause addiction or withdrawal symptoms?
Drug Abuse And Dependence
- Zohydro ER contains hydrocodone bitartrate, a Schedule II controlled substance.
- Zohydro ER contains hydrocodone, a substance with a high potential for abuse similar to other opioids including fentanyl, hydromorphone, methadone, morphine, oxycodone, oxymorphone, and tapentadol. Zohydro ER can be abused and is subject to misuse, abuse, addiction, and criminal diversion.
- The high drug content in extended release formulations adds to the risk of adverse outcomes from abuse and misuse.
- All patients treated with opioids require careful monitoring for signs of abuse and addiction as use of opioid analgesic products carries the risk of addiction even under appropriate medical use.
- Prescription drug abuse is the intentional non-therapeutic use of a prescription drug, even once, for its rewarding psychological or physiological effects. Drug addiction is a cluster of behavioral, cognitive, and physiological phenomena that develop after repeated substance use and includes: a strong desire to take the drug, difficulties in controlling its use, persisting in its use despite harmful consequences, a higher priority given to drug use then to other activities and obligations, increased tolerance, and sometimes a physical withdrawal.
- "Drug-seeking" behavior is very common in persons with substance use disorders. Drug seeking tactics include emergency calls or visits near the end of office hours, refusal to undergo appropriate examination, testing, or referral, repeated “loss” of prescriptions, tampering with prescriptions, and reluctance to provide prior medical records or contact information for other treating healthcare provider(s). “Doctor shopping” (visiting multiple prescribers to obtain additional prescriptions) is common among drug abusers, and people with untreated addiction. Preoccupation with achieving adequate pain relief can be appropriate behavior in a patient with poor pain control.
- Abuse and addiction are separate and distinct from physical dependence and tolerance. Healthcare providers should be aware that addiction may not be accompanied by concurrent tolerance and symptoms of physical dependence in all addicts. In addition, abuse of opioids can occur in the absence of true addiction.
- Zohydro ER, like other opioids, can be diverted for non-medical use into illicit channels of distribution. Careful record-keeping of prescribing information, including quantity, frequency, and renewal requests, as required by state and federal law, is strongly advised.
- Proper assessment of the patient, proper prescribing practices, periodic re-evaluation of therapy, and proper dispensing, storage, and disposal are appropriate measures that help to limit abuse of opioid drugs.
Risks Specific To Abuse Of Zohydro ER
- Zohydro ER is for oral use only. Abuse of Zohydro ER poses a risk of overdose and death. The risk is increased with concurrent use of Zohydro ER with alcohol and other central nervous system depressants. Taking cut, broken, chewed, crushed, or dissolved Zohydro ER enhances drug release and increases the risk of overdose and death.
- With intravenous abuse, the inactive ingredients in Zohydro ER can result in death, local tissue necrosis, infection, pulmonary granulomas, increased risk of endocarditis and valvular heart injury, embolism, and death. Parenteral drug abuse is commonly associated with transmission of infectious diseases such as hepatitis and HIV.
- Both tolerance and physical dependence can develop during chronic opioid therapy. Tolerance is the need for increasing doses of opioids to maintain a defined effect such as analgesia (in the absence of disease progression or other external factors). Tolerance may occur to both the desired and undesired effects of drugs, and may develop at different rates for different effects.
- Physical dependence results in withdrawal symptoms after abrupt discontinuation or a significant dosage reduction of a drug. Withdrawal also may be precipitated through the administration of drugs with opioid antagonist activity (e.g., naloxone, nalmefene), mixed agonist/antagonist analgesics (e.g., pentazocine, butorphanol, nalbuphine), or partial agonists (e.g., buprenorphine). Physical dependence may not occur to a clinically significant degree until after several days to weeks of continued opioid usage.
- Zohydro ER should not be abruptly discontinued. If Zohydro ER is abruptly discontinued in a physically-dependent patient, a withdrawal syndrome may occur. Some or all of the following can characterize this syndrome: restlessness, lacrimation, rhinorrhea, yawning, perspiration, chills, myalgia, and mydriasis. Other signs and symptoms also may develop, including: irritability, anxiety, backache, joint pain, weakness, abdominal cramps, insomnia, nausea, anorexia, vomiting, diarrhea, increased blood pressure, respiratory rate, or heart rate.
- Infants born to mothers physically dependent on opioids will also be physically dependent and may exhibit respiratory difficulties and withdrawal signs.
Zohydro ER (hydrocodone) is an opioid narcotic pain-reliever similar to oxycodone, morphine, methadone, fentanyl, and other opioids prescribed for long-term treatment of severe pain for which other treatment options are not effective, not tolerated, or would most likely not be strong enough to adequately manage the pain. Common side effects of Zohydro ER include lightheadedness, dizziness, sedation, nausea, vomiting, drowsiness, constipation, and spasm of the ureter, which can lead to difficulty in urinating. There are no adequate studies of Zohydro ER in pregnant women. Use during pregnancy can cause life-threatening withdrawal symptoms in a newborn baby. Zohydro ER is excreted in breast milk, and, therefore should be used cautiously by breastfeeding mothers.
Multimedia: Slideshows, Images & Quizzes
Pain-Relief Tips for Bumps, Bruises, Sprains, and Strains in Pictures
View this First Aid slideshow on Care and Pain Relief. See how to get pain relief if you've bumped your head, sprained your...
Pain Management: Surprising Causes of Pain
What's causing your pain? Learn the common causes of lower back pain, as well as pain in the knee, stomach, kidney, shoulder,...
Pain: Why Does My Head Ache?
Find out what's behind your headache, and get some strategies to bring you relief for your pain.
Pain Management: 15 Easy Ways to Reduce Chronic Pain
Chronic pain can be a symptom of many conditions, including arthritis, headaches, and others. Comprehensive chronic pain...
Chronic Pain Syndrome: Treatment and Management for CPS
Do you suffer from excruciating pain? What is chronic pain syndrome (CPS)? See causes, symptoms and treatment options, including...
Nerve Pain: Symptoms, Causes, and Treatment Options
Learn about nerve pain symptoms, causes, and treatment options. Discover medications and natural remedies to relieve nerve pain.
Pain Quiz: Test Your IQ of Pain
Is pain all in the brain? Take the Pain Quiz to learn everything you've ever wanted to know about the unpleasant sensation we...
Pain Management: All About CBD Oil
Cannabidiol oil: It's made from marijuana and everyone seems to be talking about it. But what is it, and what does it really do?
Pain Management: One-Move Fixes for Pain and Stress
A quick stretch, yoga pose, or on-the-spot exercise can help fix sudden aches from head to toe. Learn how to quash pain with just...
Pain Management: Visual Guide to Frozen Shoulder
It's got nothing to do with cold weather. It means your shoulder is jammed up. WebMD guides you through the causes of frozen...
Pain Management: Knee Pain Dos and Don'ts
Your knees go through a lot in the course of a day, and sometimes they can run into trouble. Here are a few things you can do...
Pain Management: All About Your Knees
They do their job so well that you might take them for granted. Learn how they're put together, what can go wrong with them, and...
Pain Management: Ergonomic Tips for a Home Office
Are you working at home? Find out how to set up a workspace to prevent stiffness, protect your muscles and joints, and avoid...
Related Disease Conditions
Pain Management and Rheumatoid Arthritis
Second Source article from WebMD
Pain management and treatment can be simple or complex, according to its cause. There are two basic types of pain, nociceptive pain and neuropathic pain. Some causes of neuropathic pain include: complex regional pain syndrome, interstitial cystitis, and irritable bowel syndrome. There are a variety of methods to treat chronic pain, which are dependant on the type of pain experienced.
Pain Relief Options for Childbirth
Women experience and tolerate pain differently. For some pregnant women, focused breathing is all they need to get through labor and childbirth; but for others, numbing of the pain is desired. There are a number of different medications a woman can take during labor and childbirth. It is important for you to learn what pain relief options are available. Please discuss the options with your health care professional well before your "birth day" so that when you are in labor you understand the choices.
Pain Management: Neuropathic Pain
Neuropathic pain is chronic pain resulting from injury to the nervous system. The injury can be to the central nervous system (brain and spinal cord) or the peripheral nervous system (nerves outside the brain and spinal cord).
Treatment & Diagnosis
- Chronic Pain: Implantable Pain Control Devices
- Pain Management
- Chronic Pain: Dealing With Back and Neck Pain
- Chronic Pain and Fatigue - What You Can Do
- Pain Management: Routes to Relief
- Chronic Pain Treatments for Mind and Body
- Pain Awareness and Management
- Pain: Managing the Pains and Aches of Office Life
- Pain Management: Painkiller Addiction
- Pain Management: Dealing with Back Pain
Medications & Supplements
- hydrocodone/acetaminophen - oral, Lortab, Norco, Vicodin
- hydrocodone/ibuprofen - oral, Vicoprofen
- hydrocodone (Zohydro ER)
- hydrocodone and ibuprofen, Vicoprofen
- hydrocodone/homatropine (Tussigon)
- chlorpheniramine and hydrocodone, Tussionex, TussiCaps, Tussionex Pennkinetic, Vituz
- Tussigon (hydrocodone)
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects, drug interactions, and addiction sections courtesy of the U.S. Food and Drug Administration.